Cancer clusters—unusual concentrations of cancer cases in a specific area over a certain period—frequently spark community anxiety and prompt formal investigations by public health agencies like the Centers for Disease Control and Prevention. While geographic investigations examine environmental links, individual health outcomes often depend on routine medical screenings that have faced prolonged national declines, according to data from the American Cancer Society.
Understanding Cancer Clusters and Public Health Investigations
Public health departments define a cancer cluster as a greater-than-expected number of cancer cases that occurs in a group of people, a geographic area, and a defined period. According to federal health agencies, communities often notice these patterns and voice alarm about potential local carcinogens. Epidemiologists investigate these reports by comparing the observed number of cases against expected rates adjusted for age, sex, and race. Many suspected clusters turn out to be random variations, though confirmed anomalies trigger deeper environmental assessments.
The Post-Pandemic Decline in Cervical Cancer Screenings
While environmental health officials investigate localized cancer patterns, national screening rates for specific malignancies continue to lag. According to the American Cancer Society, cervical cancer screening rates have not rebounded from lows hit during the COVID-19 pandemic, continuing a declining pattern spanning the past two decades. In the United States, about 13,000 new cases of cervical cancer are diagnosed annually, and about 4,000 people die from the disease, as reported by the Centers for Disease Control and Prevention.
Did you know? Routine testing targets human papillomavirus (HPV), one of the leading causes of cervical cancer. Federal health guidelines recommend that women and individuals with a cervix at average risk begin screening at age 25 and undergo primary HPV testing every five years through age 65, according to the American Cancer Society. Meanwhile, the U.S. Preventive Services Task Force recommends screening every few years starting at age 21.
Personal Impact and the Push for Routine Medical Screenings
Individual vigilance remains critical for early detection, as demonstrated by personal experiences shared publicly to encourage preventative care. Cindi Newman, 63, of Santa Rosa, California, began speaking out about routine screenings after her wife, Nikki Marshall, died of cervical cancer following a years-long battle with the disease, as told to USA TODAY. Newman admitted that both survivors of sexual abuse had avoided regular pap smears for decades due to trauma and misconceptions regarding risk. Following Marshall’s death, Newman utilized new self-screening options that detected severe precancerous dysplasia, leading to successful treatment.
FDA Approvals Expand At-Home HPV Self-Screening Options
Barriers to early detection are shifting due to recent regulatory approvals for at-home testing methods. The Food and Drug Administration approved the Teal Wand, the first at-home cervical cancer screening kit, in 2025. This followed a 2024 FDA approval allowing self-screening with a swab at a doctor’s office, and a subsequent 2026 approval for another brand of at-home collection. Following these federal approvals, the American Cancer Society added self-collected vaginal specimens to its acceptable cervical cancer screening guidelines, replacing decades-old requirements that restricted HPV testing exclusively to in-person pap smears.
Pro tip: Consult with a primary care physician to assess personal risk levels and determine the appropriate screening schedule and collection method, as individual health histories dictate the best preventative approach.
Frequently Asked Questions About Cervical Cancer Screening
What is a cancer cluster?
A cancer cluster is an unusual concentration of cancer cases in a specific geographic area over a defined period, which health departments evaluate to determine if rates exceed statistical expectations.
Who should get screened for cervical cancer?
According to the American Cancer Society, individuals with a cervix at average risk should begin screening at age 25 and undergo primary HPV testing every five years through age 65.
Are at-home HPV tests approved by the FDA?
Yes. The FDA approved at-home cervical cancer screening collection methods in 2025 and 2026, allowing patients to collect samples via a vaginal swab outside of a clinical setting.
Can self-collected HPV swabs replace traditional pap smears?
The American Cancer Society recognizes self-collected vaginal specimens as an acceptable screening method within their clinical guidelines, though patients should consult healthcare providers regarding follow-up care if high-risk HPV is detected.
To read more coverage on public health investigations and preventative medicine developments, explore our latest reporting or subscribe to our newsletter for updates.
Keep reading